Pediatrix Medical Group Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pediatrix Medical Group Inc 's ROA in the third quarter of 2026?
Pediatrix Medical Group Inc achieved a return on average assets (ROA) of 6.99 % in its third quarter of 2026, this is above MD's average return on assets of 1.44%.
Pediatrix Medical Group Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion

ROA fell compared to the second quarter of 2026, despite the net income growth of 17.94% from the second quarter of 2026.

However, within the Healthcare sector 126 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 766, from total ROA ranking in the second quarter of 2026 at 932.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	-2.73 %	1.34 %	3.85 %	11.63 %	15.6 %
Y / Y Net Income Change	-34.47 %	1.48 %	42.61 %	10.51 %	268.85 %
Net Income (TTM) in million	150	175	174	165	162
Return On Assets (TTM)	6.99 %	8.09 %	8.09 %	7.74 %	7.81 %
MD's Total Ranking	# 766	# 932	# 812	# 1138	# 3014
Total Assets (TTM) in million	2,139	2,130	2,070	2,247	2,199
Seq. Total Assets Change	0.43 %	2.9 %	-7.85 %	2.15 %	4.63 %
Seq. Net Income Change	17.94 %	34.73 %	-12.2 %	-53.03 %	82.65 %

MD's 5 Years Annual ROA >> Back to MD Management Effectiveness >> Compare MD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 15
Sector	# 127
Overall	# 894

Return On Assets Statistics
High	Average	Low
11.35 %	1.44 %	-48.01 %
(Jun 30 2011)		(Jun 30 2020)

Financial Statements
Pediatrix Medical Group Inc 's Assets	$ 2,139 million	MD's Balance sheet
Pediatrix Medical Group Inc 's Income	$ 47 million	Quarterly MD's Income Statement
MD's Income by Division		See MD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	11.63 %	-1.78 %	-5.91 %	-20.01 %	-18.68 %
Total Assets in million	2,247	2,013	2,049	2,178	2,723
Y / Y Net Income Change	-	-	-	-49.34 %	-
Net Income in million	165	-99	-60	66	131
Annual Return On Assets	7.36 %	-4.92 %	-2.95 %	3.05 %	4.81 %

MD's 5 Years Annual ROA >> Back to MD Management Effectiveness >> Compare MD ROA to its Competitors

Comment on MD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 7.36 % compared to prior year, due to annual net income growth of % to $165.39 million, while value of Pediatrix Medical Group Inc 's overall assets grew just by 11.63 % to $2,246.70 million, compared to $2,246.70 a year before.

More Return On Assets Ratios
MD's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MD's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MD's Competitors
Subscribers only: Roa for Pediatrix Medical Group Inc 's Suppliers
Subscribers only: Return On Assets for MD's Customers

You may also want to know
MD's Roi	MD's Inventory Turnover Ratio	MD's Growth Rates	MD's Dividend Comparisons
	MD's Profitability Ratios	MD's Asset Turnover Ratio	MD's Dividend Growth
MD's Roe	MD's Valuation Ratios	MD's Financial Strength Ratios	MD's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %

Date modified: 2026-10-30T13:16:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.